Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1830 clinical trials
Featured trial
Combined Exercise and Cognitive Stimulation for Falls Prevention

Randomized clinical trial of 310 older adults over 75 years old recruited from the Falls Units of Geriatric Departments in 4 three University Hospitals in Spain (Pamplona, San Sebastin, Albacete and Barcelona). Participants who met inclusion criteria will be randomized to the usual care group (Otago exercise program) or the …

  • 0 views
  • 04 Jun, 2021
Featured trial
Nutrition Intervention Integrated With Food Voucher to Improve Child Growth and Feeding Practices  

Baseline and endline survey will be conducted. Growth Monitoring Promotion (GMP) will be done monthly to monitor the growth of the children and utilization of food voucher.

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 1 location
Featured trial
Redefining BMI: The Body, Mind, and Inflammation Trial

The primary purpose of this study is to test the preliminary efficacy of the intensive lifestyle intervention for EA women in reducing adiposity, as well as improving biomarkers of inflammation and metabolic risk over 12 months compared with a traditional behavioral weight loss intervention. This treatment program will be tested …

  • 0 views
  • 02 Mar, 2026
  • 2 locations
Featured trial
Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Healthy volunteers, chest pain patients who will receive CAG or CTA examination, and patients with acute myocardial infarction will be enrolled in this study.

Accepts healthy volunteers
  • 0 views
  • 10 Nov, 2025
Featured trial
IPG7236 in Patients With Advanced Solid Tumors  

Each part will consist of a screening period of up to 28 days, a treatment period, an end of treatment visit and a safety follow-up of approximately 30 days after the last dose. IPG7236 will be given on an empty stomach (either one hour before or two hours after a …

  • 0 views
  • 14 Mar, 2022
  • 1 location
Featured trial
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs (KYANITE-1)

Subjects in Cohort 7 are receiving inhaled KB707 in combination with docetaxel once every 3 weeks.All subjects will be treated until tumor progression, death, unacceptable toxicity, symptomatic deterioration, achievement of maximal response, subject choice, Investigator decision to discontinue treatment, or the Sponsor determines to terminate the study.

  • 0 views
  • 12 Dec, 2025
Featured trial
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation (IMPACT-D)  

Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

  • 0 views
  • 17 Oct, 2025
Featured trial
Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer (Rideau)

We will conduct a Phase I trial testing whether local cystoscopic injection of tremelimumab into the bladder wall in combination with systemic administration of durvalumab in localized bladder cancer will stimulate an effective anti-tumour immune response with minimal systemic immune response and clinical toxicity.

  • 0 views
  • 14 Mar, 2022
  • 1 location
Featured trial
  • 0 views
  • 17 Nov, 2021
  • 1 location
Featured trial
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST)

Primary Objective -To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smell Secondary Objectives To evaluate the efficacy of dupilumab in improving CRSwNP symptoms at Week 24 compared to omalizumab To evaluate the efficacy of dupilumab in improving lung function at …

  • 0 views
  • 17 Nov, 2021
  • 1 location